Cardiva Medical, Inc.

Cardiva Medical, Inc. designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional endovascular procedures. Since its founding, Cardiva has introduced a series of advanced vascular access management technologies designed to help the body heal itself.

Cardiva Medical, Inc. is a privately-held company funded by leading venture capital investors, including PTV Healthcare Captial, Canepa Advanced Healthcare Fund, L.P and Amkey Ventures LLC. Cardiva was presented the prestigious Frost & Sullivan Entrepreneurial Company Award, which recognizes entrepreneurial excellence in the U.S. angioplasty and vascular closure device markets.